:: infobox .infobox-celltype
Allen Atlas ID: CS202210140_3700
Lineage: Glial > Oligodendrocyte > Myelinating Oligodendrocyte
Markers: MBP, PLP1, OLIG2, SOX10, MOG, CNP
Brain Regions: White matter tracts, subcortical regions, corpus callosum
Disease Vulnerability: Multiple Sclerosis, Alzheimer's Disease, ALS, Leukodystrophies
::
Oligodendrocytes is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Oligodendrocytes are the myelinating cells of the central nervous system (CNS), responsible for producing the myelin sheath that wraps around axons to enable rapid saltatory conduction of nerve impulses. Each oligodendrocyte can myelinate multiple axons—typically 20-60 internodes—making them highly efficient. Oligodendrocytes arise from oligodendrocyte progenitor cells (OPCs) in the developing brain and continue to mature throughout early adulthood. Beyond myelination, oligodendrocytes provide metabolic support to axons through the myelin sheath, which contains glucose transporters and lactate channels that transfer energy substrates to [neurons[/entities/[neurons[/entities/[neurons[/entities/[neurons--TEMP--/entities)--FIX--. Oligodendrocyte dysfunction is central to demyelinating diseases like multiple sclerosis (MS) and is increasingly recognized in neurodegenerative diseases including Alzheimer's disease, ALS, and various leukodystrophies.
OPCs are the proliferative precursors to oligodendrocytes:
Oligodendrocyte development follows a defined sequence:
The primary function of oligodendrocytes:
Oligodendrocytes provide crucial metabolic support:
Oligodendrocyte support for axonal survival:
Central to MS pathophysiology:
Emerging role in AD:
Oligodendrocyte involvement in ALS:
The study of Oligodendrocytes has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
✓ Established
Fluorescence excitation/emission spectra of amyloid-binding dyes, when analyzed with machine learning (PCA, UMAP, neural networks), can distinguish distinct conformational amyloid strains in vitro and in situ
Successfully identified 6 distinct conformational strains in vitro with 98% discrimination; validated on transgenic mouse models and human brain samples showing distinct clustering for different disease types
◉ Supported
Different neurodegenerative diseases (sAD, fAD PSEN1, fAD APP, Down syndrome) have distinct conformational strains of Aβ plaques that can be differentiated spectroscopically
UMAP plots show 99% discrimination between sAD and fAD; fAD PSEN1 and fAD APP clusters overlap; DS forms separate cluster with patient-specific subclusters
◉ Supported
Tau tangles from different neurodegenerative diseases (sAD, fAD, DS, Pick's disease) exist as distinct conformational strains
PCA and UMAP show 5 distinct clusters for tau tangles across diseases; fAD PSEN1 and fAD APP share cluster suggesting same tau strain induced by different Aβ backgrounds; PiD tau clearly separated from AD tau
✓ Established
Fluorescence excitation/emission spectra of amyloid-binding dyes, when analyzed with machine learning (PCA, UMAP, neural networks), can distinguish distinct conformational amyloid strains in vitro and in situ
Successfully identified 6 distinct conformational strains in vitro with 98% discrimination; validated on transgenic mouse models and human brain samples showing distinct clustering for different disease types
◉ Supported
Different neurodegenerative diseases (sAD, fAD PSEN1, fAD APP, Down syndrome) have distinct conformational strains of Aβ plaques that can be differentiated spectroscopically
UMAP plots show 99% discrimination between sAD and fAD; fAD PSEN1 and fAD APP clusters overlap; DS forms separate cluster with patient-specific subclusters
◉ Supported
Tau tangles from different neurodegenerative diseases (sAD, fAD, DS, Pick's disease) exist as distinct conformational strains
PCA and UMAP show 5 distinct clusters for tau tangles across diseases; fAD PSEN1 and fAD APP share cluster suggesting same tau strain induced by different Aβ backgrounds; PiD tau clearly separated from AD tau
✓ Established
Fluorescence excitation/emission spectra of amyloid-binding dyes, when analyzed with machine learning (PCA, UMAP, neural networks), can distinguish distinct conformational amyloid strains in vitro and in situ
Successfully identified 6 distinct conformational strains in vitro with 98% discrimination; validated on transgenic mouse models and human brain samples showing distinct clustering for different disease types
◉ Supported
Different neurodegenerative diseases (sAD, fAD PSEN1, fAD APP, Down syndrome) have distinct conformational strains of Aβ plaques that can be differentiated spectroscopically
UMAP plots show 99% discrimination between sAD and fAD; fAD PSEN1 and fAD APP clusters overlap; DS forms separate cluster with patient-specific subclusters
◉ Supported
Tau tangles from different neurodegenerative diseases (sAD, fAD, DS, Pick's disease) exist as distinct conformational strains
PCA and UMAP show 5 distinct clusters for tau tangles across diseases; fAD PSEN1 and fAD APP share cluster suggesting same tau strain induced by different Aβ backgrounds; PiD tau clearly separated from AD tau
Nave KA, Werner HB. "Myelination of the nervous system: mechanisms and functions." Annual Review of Cell and Developmental Biology (2014). PMID:25288117
Bergles DE, Richardson WD. "Oligodendrocyte development in the adult brain." Nature Reviews Neuroscience (2015). PMID:26597290
Fancy SP, Chan JR, Baranzini SE, et al. "Myelin regeneration: a recapitulation of development?" Annual Review of Neuroscience (2011). PMID:21663440
Simons M, Nave KA. "Oligodendrocytes: myelination and axonal support." Cold Spring Harbor Perspectives in Biology (2015). PMID:26054784
Saab AS, Nave KA. "Myelinic mitochondria: keeping the brain wired." Neuron (2017). PMID:28406958
Franklin RJ, ffrench-Constant C. "Remyelination in the CNS: from biology to therapy." Nature Reviews Neuroscience (2018). PMID:30297695
Lee Y, Morrison BM, Li Y, et oligodendrocyte support and cause neurodegeneration in ALS." Nature (2012). PMID:23272130
Miron VE, Kuhlmann T, Antel JP. "Cells of the oligodendroglial lineage, and neurodegeneration." Neurochemical Research (2011). PMID:21792516